Stay updated on Taldefgrobep Alfa in SMA Clinical Trial
Sign up to get notified when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.

Latest updates to the Taldefgrobep Alfa in SMA Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedUpdated medical term from Proximal spinal muscular atrophy to spinal muscular atrophy and bumped revision to v3.2.0; added a government operations status notice. Removed the more specific term and previous version label.SummaryDifference4%

- Check35 days agoChange DetectedUpdated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous v3.0.1, indicating a new release. The 'Back to Top' element has been removed.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as changes to the resources related to genetic and rare diseases. Notably, the page now includes updated certification dates and a revision number.SummaryDifference5%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Taldefgrobep Alfa in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.